{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T22:42:45Z","timestamp":1788388965363,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Chang Gung","award":["CMRPG6E0161"],"award-info":[{"award-number":["CMRPG6E0161"]}]},{"DOI":"10.13039\/100001236","name":"Medical Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001236","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"name":", Keelung"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.phymed.2019.152879","type":"journal-article","created":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T02:41:05Z","timestamp":1551148865000},"page":"152879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["The anti-angiogenic effect of tryptanthrin is mediated by the inhibition of apelin promoter activity and shortened mRNA half-life in human vascular endothelial cells"],"prefix":"10.1016","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2474-7785","authenticated-orcid":false,"given":"Hsin-Ning","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Chieh","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho-Yen","family":"Chueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hwei S.","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2019.152879_bib0001","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.18632\/oncotarget.2032","article-title":"Apelin promotes lymphangiogenesis and lymph node metastasis","volume":"5","author":"Berta","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2019.152879_bib0002","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jep.2015.08.050","article-title":"Indigo naturalis and its component tryptanthrin exert anti-angiogenic effect by arresting cell cycle and inhibiting Akt and FAK signaling in human vascular endothelial cells","volume":"174","author":"Chang","year":"2015","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phymed.2019.152879_bib0003","doi-asserted-by":"crossref","first-page":"6423","DOI":"10.3390\/molecules15096423","article-title":"Inhibitory effect of indigo naturalis on tumor necrosis factor-alpha-induced vascular cell adhesion molecule-1 expression in human umbilical vein endothelial cells","volume":"15","author":"Chang","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.phymed.2019.152879_bib0004","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10456-007-9074-0","article-title":"Angiogenesis and chronic inflammation: cause or consequence?","volume":"10","author":"Costa","year":"2007","journal-title":"Angiogenesis"},{"key":"10.1016\/j.phymed.2019.152879_bib0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ydbio.2006.04.452","article-title":"Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo","volume":"296","author":"Cox","year":"2006","journal-title":"Dev. Biol."},{"key":"10.1016\/j.phymed.2019.152879_bib0006","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1024515517623","article-title":"Angiogenesis in psoriasis","volume":"5","author":"Creamer","year":"2002","journal-title":"Angiogenesis"},{"key":"10.1016\/j.phymed.2019.152879_bib0007","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejphar.2006.09.034","article-title":"Apelin increases contractility in failing cardiac muscle","volume":"553","author":"Dai","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152879_bib0008","doi-asserted-by":"crossref","first-page":"144","DOI":"10.5798\/diclemedj.0921.2014.01.0389","article-title":"Investigation of adiponectin, leptin and apelin levels in patients with psoriasis vulgaris","volume":"41","author":"Alata\u015fand","year":"2014","journal-title":"Dicle Med. J."},{"key":"10.1016\/j.phymed.2019.152879_bib0009","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1084\/jem.180.3.1141","article-title":"Overexpression of vascular permeability factor\/vascular endothelial growth factor and its receptors in psoriasis","volume":"180","author":"Detmar","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phymed.2019.152879_bib0010","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.jaad.2006.07.019","article-title":"Off-label uses of biologics in dermatology: rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (part 2 of 2)","volume":"56","author":"Graves","year":"2007","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.phymed.2019.152879_bib0011","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1365-2613.2009.00669.x","article-title":"Angiogenesis drives psoriasis pathogenesis","volume":"90","author":"Heidenreich","year":"2009","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.phymed.2019.152879_bib0012","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1055\/s-0028-1097245","article-title":"Isolation of antifungal principle tryptanthrin, from Strobilanthes cusia O","volume":"36","author":"Honda","year":"1979","journal-title":"Kuntze. Planta Med."},{"key":"10.1016\/j.phymed.2019.152879_bib0013","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2340\/00015555-1737","article-title":"Phosphoinositide-3 kinase\/protein kinase-B\/mammalian target of rapamycin pathway in psoriasis pathogenesis. A potential therapeutic target?","volume":"94","author":"Huang","year":"2014","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.phymed.2019.152879_bib0014","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0014-2999(00)00674-9","article-title":"Tryptanthrin inhibits nitric oxide and prostaglandin E (Plotkin, Stemmer-Rachamimov et\u00a0al.) synthesis by murine macrophages","volume":"407","author":"Ishihara","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phymed.2019.152879_bib0015","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/cam4.385","article-title":"Development and validation of the functional assessment of cancer therapy-antiangiogenesis subscale","volume":"4","author":"Kaiser","year":"2015","journal-title":"Cancer Med."},{"key":"10.1016\/j.phymed.2019.152879_bib0016","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1586\/1744666X.4.1.93","article-title":"Targeting signaling pathways with small molecules to treat autoimmune disorders","volume":"4","author":"Kaminska","year":"2008","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.phymed.2019.152879_bib0045","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s005350170147","article-title":"Antibacterial action of tryptanthrin and kaempferol, isolated from the indigo plant (Polygonum tinctorium Lour.), against Helicobacter pylori-infected Mongolian gerbils","volume":"36","author":"Kataoka","year":"2001","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.phymed.2019.152879_bib0017","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0167-4889(00)00143-9","article-title":"Molecular properties of apelin: tissue distribution and receptor binding","volume":"1538","author":"Kawamata","year":"2001","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phymed.2019.152879_bib0018","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1182\/blood-2009-07-232306","article-title":"Apelin induces enlarged and nonleaky blood vessels for functional recovery from ischemia","volume":"115","author":"Kidoya","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.phymed.2019.152879_bib0019","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1152\/physiolgenomics.00271.2005","article-title":"Transcriptomes of purified gastric ECL and parietal cells: identification of a novel pathway regulating acid secretion","volume":"25","author":"Lambrecht","year":"2006","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.phymed.2019.152879_bib0020","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1046\/j.1440-1827.2001.01204.x","article-title":"Cell differentiation and apoptosis of monocytic and promyelocytic leukemia cells (U-937 and HL-60) by tryptanthrin, an active ingredient of Polygonum tinctorium Lour","volume":"51","author":"Kimoto","year":"2001","journal-title":"Pathol. Int."},{"key":"10.1016\/j.phymed.2019.152879_bib0046","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.phrs.2013.01.005","article-title":"PIM1 kinase inhibitors induce radiosensitization in non-small cell lung cancer cells","volume":"70","author":"Kim","year":"2013","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phymed.2019.152879_bib0044","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.cbi.2013.03.001","article-title":"Tryptanthrin induces growth inhibition and neuronal differentiation in the human neuroblastoma LA-N-1 cells","volume":"203","author":"Liao","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.phymed.2019.152879_bib0021","doi-asserted-by":"crossref","first-page":"e82294","DOI":"10.1371\/journal.pone.0082294","article-title":"Tryptanthrin inhibits angiogenesis by targeting the VEGFR2-mediated ERK1\/2 signalling pathway","volume":"8","author":"Liao","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.phymed.2019.152879_bib0022","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1001\/archderm.144.11.1457","article-title":"Clinical assessment of patients with recalcitrant psoriasis in a randomized, observer-blind, vehicle-controlled trial using indigo naturalis","volume":"144","author":"Lin","year":"2008","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.phymed.2019.152879_bib0023","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jdermsci.2009.02.007","article-title":"Anti-psoriatic effects of indigo naturalis on the proliferation and differentiation of keratinocytes with indirubin as the active component","volume":"54","author":"Lin","year":"2009","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.phymed.2019.152879_bib0024","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archdermatol.2011.1091","article-title":"Comparison of refined and crude indigo naturalis ointment in treating psoriasis: randomized, observer-blind, controlled, intrapatient trial","volume":"148","author":"Lin","year":"2012","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.phymed.2019.152879_bib0025","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000098576","article-title":"The efficacy and safety of topically applied indigo naturalis ointment in patients with plaque-type psoriasis","volume":"214","author":"Lin","year":"2007","journal-title":"Dermatol"},{"key":"10.1016\/j.phymed.2019.152879_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/760691","article-title":"Evaluation of adipokines: apelin, visfatin, and resistin in children with atopic dermatitis","volume":"2013","author":"Machura","year":"2013","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.phymed.2019.152879_bib0027","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics","volume":"58","author":"Menter","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.phymed.2019.152879_bib0028","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.jaad.2008.12.032","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies","volume":"60","author":"Menter","year":"2009","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.phymed.2019.152879_bib0029","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.3390\/ijms12063831","article-title":"Proliferation-attenuating and apoptosis-inducing effects of tryptanthrin on human chronic myeloid leukemia k562 cell line in vitro","volume":"12","author":"Miao","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phymed.2019.152879_bib0030","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/1523-1747.ep12465237","article-title":"Proliferating cells in psoriatic dermis are comprised primarily of T cells, endothelial cells, and factor XIIIa+ perivascular dendritic cells","volume":"96","author":"Morganroth","year":"1991","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.phymed.2019.152879_bib0031","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/jid.2012.339","article-title":"Global epidemiology of psoriasis: a systematic review of incidence and prevalence","volume":"133","author":"Parisi","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.phymed.2019.152879_bib0032","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1055\/s-2006-931562","article-title":"Anti-inflammatory and antiallergic activity in vivo of lipophilic Isatis tinctoria extracts and tryptanthrin","volume":"72","author":"Recio","year":"2006","journal-title":"Planta Med."},{"key":"10.1016\/j.phymed.2019.152879_bib0033","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1038\/sj.jid.5700874","article-title":"Upregulation of hypoxia-inducible factors in normal and psoriatic skin","volume":"127","author":"Rosenberger","year":"2007","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.phymed.2019.152879_bib0034","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.fob.2013.08.001","article-title":"Preferential apelin-13 production by the proprotein convertase PCSK3 is implicated in obesity","volume":"3","author":"Shin","year":"2013","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.phymed.2019.152879_bib0035","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00395-007-0671-2","article-title":"Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury","volume":"102","author":"Simpkin","year":"2007","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.phymed.2019.152879_bib0036","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.regpep.2005.05.004","article-title":"The APJ receptor is expressed in pancreatic islets and its ligand, apelin, inhibits insulin secretion in mice","volume":"131","author":"Sorhede Winzell","year":"2005","journal-title":"Regul. Peptides"},{"key":"10.1016\/j.phymed.2019.152879_bib0037","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.1038\/sj.onc.1210573","article-title":"Apelin is a potent activator of tumour neoangiogenesis","volume":"26","author":"Sorli","year":"2007","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.phymed.2019.152879_bib0038","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1006\/bbrc.1998.9489","article-title":"Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor","volume":"251","author":"Tatemoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phymed.2019.152879_bib0039","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.cca.2016.12.023","article-title":"Apelin\/APJ system: a novel promising therapy target for pathological angiogenesis","volume":"466","author":"Wu","year":"2017","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.phymed.2019.152879_bib0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/CAD.0b013e32832a2cd4","article-title":"Downregulation of GSTpi expression by tryptanthrin contributing to sensitization of doxorubicin-resistant MCF-7 cells through c-jun NH2-terminal kinase-mediated apoptosis","volume":"20","author":"Yu","year":"2009","journal-title":"Anti-cancer Drugs"},{"key":"10.1016\/j.phymed.2019.152879_bib0041","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.3892\/mmr.2015.4691","article-title":"Hypoxia induces the proliferation of endothelial progenitor cells via upregulation of Apelin\/APLNR\/MAPK signaling","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phymed.2019.152879_bib0042","doi-asserted-by":"crossref","first-page":"325","DOI":"10.18433\/J3501W","article-title":"Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells","volume":"14","author":"Zhu","year":"2011","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.phymed.2019.152879_bib0043","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0014-5793(00)01487-3","article-title":"Apelin peptides block the entry of human immunodeficiency virus (HIV)","volume":"473","author":"Zou","year":"2000","journal-title":"FEBS Lett."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711319300492?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711319300492?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T18:18:00Z","timestamp":1760552280000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711319300492"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":46,"alternative-id":["S0944711319300492"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2019.152879","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The anti-angiogenic effect of tryptanthrin is mediated by the inhibition of apelin promoter activity and shortened mRNA half-life in human vascular endothelial cells","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2019.152879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152879"}}